The researchers receive over $ 1 million to study the molecular foundations - pancreatic cancer
Alexandros Tzatsos, MD, Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University school of medicine and health sciences, has received over one million dollars in the health of the national Institutes grants to study the molecular basis of pancreatic cancer.
in May, Tzatsos received a R00 price for $ 706K, which is the second phase of a National Cancer Institute K99 / R00 Howard Temin Pathway to Independence Award in Cancer Research - a subsidy for to help young researchers to establish independent research laboratories. This grant will support his research project, "The role of epigenetic regulators in pancreatic cancer." In February, Tzatsos also received a R21 price $ 374K to fund his research project, "Elucidating and targeting epigenetic oncogenic Networks in pancreatic cancer. "
According to the American cancer Society, pancreatic cancer is the fourth leading cause of death in rare cases US cancer be found early enough for effective treatment . Tzatsos studies the role of a histone demethylase resulting in the development of pancreatic cancer and generated genetically modified mouse models new to address the role of this epigenetic regulator in vivo.
"We propose use these mouse models to study pancreatic cancer and to develop targeted therapies in preclinical level, "Tzatsos said. "This could be the key to understanding the molecular pathology of pancreatic cancer and develop better therapies."
EmoticonEmoticon